Newstral
Article
Reuters on 2020-04-08 10:11
Boehringer Ingelheim fährt auf Sicht - Keine Prognose wegen Corona-Krise
Related news
- DBoehringer Ingelheim settles litigation over Humira biosimilardailyvoiceplus.com
- DBoehringer Ingelheim acquires Swiss biotech Amal Therapeuticsdailyvoiceplus.com
- Reederei Hapag Lloyd fährt in der Corona-Krise auf SichtReuters
- Hundreds of workers laid off in Boehringer Ingelheim cutswtnh.com
- Boehringer Ingelheim cutting 725 jobs, including 50 in Ridgefieldwestfaironline.com
- Boehringer Ingelheim eliminating another 120 positions in Ridgefieldwestfaironline.com
- Boehringer Ingelheim cuts Connecticut jobs after sales fallMerced Sun-Star
- Hohe Nachfrage nach Diabetesmitteln gibt Boehringer Ingelheim SchwungReuters
- Boehringer Ingelheim teams with Yale on biomedical fellowship programwestfaironline.com
- Boehringer Ingelheim attacks IBD collaborativelywestfaironline.com
- Boehringer Ingelheim tops for femalestheridgefieldpress.com
- HeidelbergCement zieht wegen Coronavirus-Krise Prognose zurückReuters
- Boehringer Ingelheim lays off 120 employees; announces launch of new cancer research group in 2017theridgefieldpress.com
- Ridgefield’s Boehringer Ingelheim launches Global Support Program to fight COVID-19westfaironline.com
- Boehringer Ingelheim, Vanderbilt study cancer drugstheridgefieldpress.com
- Boehringer Ingelheim kooperiert mit südkoreanischer YuhanReuters
- Boehringer Ingelheim acquires ViraTherapeutics for $245 millionwestfaironline.com
- Boehringer Ingelheim on best companies listtheridgefieldpress.com
- Boehringer Ingelheim inhalation spray gets FDA approvalwestfaironline.com